FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381885412> ?p ?o ?g. }

• W4381885412 endingPage "673" @default.
• W4381885412 startingPage "671" @default.
• W4381885412 abstract "In The Lancet, Juan P Frias and colleagues report positive results in a phase 2 trial evaluating the safety and efficacy of co-administered cagrilintide and semaglutide (CagriSema) for type 2 diabetes, 1 Frias JP Deenadayalan S Erichsen L et al. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023; (published online June 23.)https://doi.org/10.1016/S0140-6736(23)01163-7 Summary Full Text Full Text PDF Scopus (2) Google Scholar approximately 2 years after a phase 1b study showed early efficacy in the treatment of obesity. 2 Enebo LB Berthelsen KK Kankam M et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021; 397: 1736-1748 Summary Full Text Full Text PDF PubMed Scopus (124) Google Scholar The role of a gut–brain axis in energy balance has been intensely studied since the 1994 discovery of leptin as a hormone produced by adipose tissue in response to feeding. 3 Zhang Y Proenca R Maffei M Barone M Leopold L Friedman JM Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-432 Crossref PubMed Scopus (11887) Google Scholar In the years that followed, many investigations led to the current understanding of energy regulation to include signalling in the liver and endocrine pancreas through both classic incretins (eg, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 [GLP-1]) and the unique hormone co-secreted with insulin (amylin). Research also showed that abnormal energy balance can be improved by perturbing the axis via altering or bypassing segments of the gastrointestinal tract with bariatric surgery. 4 Ashrafian H le Roux CW Metabolic surgery and gut hormones—a review of bariatric entero-humoral modulation. Physiol Behav. 2009; 97: 620-631 Crossref PubMed Scopus (89) Google Scholar And nearly 30 years later, gut hormone analogues, notably liraglutide, semaglutide, and tirzepatide, have been investigated as effective treatments for both type 2 diabetes and obesity. CagriSema is currently also being evaluated as a drug to treat both type 2 diabetes and obesity. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialIn people with type 2 diabetes, treatment with CagriSema resulted in clinically relevant improvements in glycaemic control (including CGM parameters). The mean change in HbA1c with CagriSema was greater versus cagrilintide, but not versus semaglutide. Treatment with CagriSema resulted in significantly greater weight loss versus semaglutide and cagrilintide and was well tolerated. These data support further investigation of CagriSema in this population in longer and larger phase 3 studies. Full-Text PDF" @default.
• W4381885412 created "2023-06-25" @default.
• W4381885412 creator A5002091941 @default.
• W4381885412 creator A5022112585 @default.
• W4381885412 date "2023-08-01" @default.
• W4381885412 modified "2023-10-16" @default.
• W4381885412 title "CagriSema and the link between obesity and type 2 diabetes" @default.
• W4381885412 cites W1996713062 @default.
• W4381885412 cites W2024948353 @default.
• W4381885412 cites W2042211138 @default.
• W4381885412 cites W2571158149 @default.
• W4381885412 cites W2572398654 @default.
• W4381885412 cites W2888010794 @default.
• W4381885412 cites W3036199105 @default.
• W4381885412 cites W3127371223 @default.
• W4381885412 cites W3155125407 @default.
• W4381885412 cites W3177393241 @default.
• W4381885412 cites W4220955649 @default.
• W4381885412 cites W4281934192 @default.
• W4381885412 cites W4381885413 @default.
• W4381885412 doi "https://doi.org/10.1016/s0140-6736(23)01291-6" @default.
• W4381885412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37364591" @default.
• W4381885412 hasPublicationYear "2023" @default.
• W4381885412 type Work @default.
• W4381885412 citedByCount "1" @default.
• W4381885412 countsByYear W43818854122023 @default.
• W4381885412 crossrefType "journal-article" @default.
• W4381885412 hasAuthorship W4381885412A5002091941 @default.
• W4381885412 hasAuthorship W4381885412A5022112585 @default.
• W4381885412 hasConcept C126322002 @default.
• W4381885412 hasConcept C134018914 @default.
• W4381885412 hasConcept C197934379 @default.
• W4381885412 hasConcept C2777180221 @default.
• W4381885412 hasConcept C2778375690 @default.
• W4381885412 hasConcept C2779473830 @default.
• W4381885412 hasConcept C2781308992 @default.
• W4381885412 hasConcept C2909862629 @default.
• W4381885412 hasConcept C511355011 @default.
• W4381885412 hasConcept C55493867 @default.
• W4381885412 hasConcept C555293320 @default.
• W4381885412 hasConcept C71924100 @default.
• W4381885412 hasConcept C83867959 @default.
• W4381885412 hasConcept C86803240 @default.
• W4381885412 hasConceptScore W4381885412C126322002 @default.
• W4381885412 hasConceptScore W4381885412C134018914 @default.
• W4381885412 hasConceptScore W4381885412C197934379 @default.
• W4381885412 hasConceptScore W4381885412C2777180221 @default.
• W4381885412 hasConceptScore W4381885412C2778375690 @default.
• W4381885412 hasConceptScore W4381885412C2779473830 @default.
• W4381885412 hasConceptScore W4381885412C2781308992 @default.
• W4381885412 hasConceptScore W4381885412C2909862629 @default.
• W4381885412 hasConceptScore W4381885412C511355011 @default.
• W4381885412 hasConceptScore W4381885412C55493867 @default.
• W4381885412 hasConceptScore W4381885412C555293320 @default.
• W4381885412 hasConceptScore W4381885412C71924100 @default.
• W4381885412 hasConceptScore W4381885412C83867959 @default.
• W4381885412 hasConceptScore W4381885412C86803240 @default.
• W4381885412 hasIssue "10403" @default.
• W4381885412 hasLocation W43818854121 @default.
• W4381885412 hasLocation W43818854122 @default.
• W4381885412 hasOpenAccess W4381885412 @default.
• W4381885412 hasPrimaryLocation W43818854121 @default.
• W4381885412 hasRelatedWork W1966504330 @default.
• W4381885412 hasRelatedWork W1979139803 @default.
• W4381885412 hasRelatedWork W2030889776 @default.
• W4381885412 hasRelatedWork W2037631372 @default.
• W4381885412 hasRelatedWork W2040058909 @default.
• W4381885412 hasRelatedWork W2132898409 @default.
• W4381885412 hasRelatedWork W2350153196 @default.
• W4381885412 hasRelatedWork W2748952813 @default.
• W4381885412 hasRelatedWork W4289021731 @default.
• W4381885412 hasRelatedWork W2182556628 @default.
• W4381885412 hasVolume "402" @default.
• W4381885412 isParatext "false" @default.
• W4381885412 isRetracted "false" @default.
• W4381885412 workType "article" @default.